Showing results (1271-1280 of 16,643) with videos related to
Sort By:
Pageof 1,665
Cancer Letters|March 18, 2018
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancerPatricia Fernández-Nogueira, Aleix Noguera-Castells, Gemma Fuster, et al.Cancer Letters|February 10, 2018
Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancerYun Zhang, Qin Lin, Ting Xu, et al.Cancer Letters|February 10, 2018
ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3WanYing Lin, Jie Luo, Yin Sun, et al.Cancer Letters|November 28, 2017
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasisChangki Lee, Young Mi Whang, Preston Campbell, et al.Cancer Letters|November 28, 2017
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7gXiaoli Cai, Xiao Wang, Can Cao, et al.Cancer Letters|November 28, 2017
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghostsAndrea Mohr, Ralf ZwackaCancer Letters|November 26, 2018
Connexin 43 (Cx43) in cancer: Implications for therapeutic approaches via gap junctionsEmily E Bonacquisti, Juliane NguyenCancer Letters|December 10, 2017
Prohibitin: A new player in immunometabolism and in linking obesity and inflammation with cancerYang Xin Zi Xu, Sudharsana Rao Ande, Suresh MishraCancer Letters|December 4, 2018
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblastsRangasudhagar Radhakrishnan, Ji Hee Ha, Muralidharan Jayaraman, et al.Cancer Letters|December 4, 2018
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinomaRuiqi Liu, Yuejin Li, Lantian Tian, et al.Pageof 1,665